Decreased sirtuin 1 in type 2 diabetes patients with abnormal BMD
Yao Xu, Tianxiao Hu, Peiwu Jiang, Xiujing Wang, Jiaqi Yao, Huiling Shen, Zhenying Zhang, Bojing Zheng, Ting Wang, Yanxia Ren, Jing Wang, Qingying Tan · 2025
Read Decreased sirtuin 1 in type 2 diabetes patients with abnormal BMD by Yao Xu, Tianxiao Hu, Peiwu Jiang, Xiujing Wang, Jiaqi Yao, Huiling Shen, Zhenying Zhang, Bojing Zheng, Ting Wang, Yanxia Ren, Jing Wang, Qingying Tan (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11813776.txt.
Description
Yao Xu and co-authors measure a longevity-linked protein in people newly diagnosed with type 2 diabetes, in a study published in 2024. The protein, sirtuin 1, helps bone-building cells grow and slows the cells that eat bone, so it may tie diabetes to weak bones. The team compared sixty-nine new diabetes patients with eighty-two people with normal blood sugar, scanning bone density and blood markers.
Sirtuin 1 levels ran significantly lower in the diabetes group, and osteoporosis was nearly twice as common among them. Within the diabetes group, those with thin bones showed the protein dropped further still. The authors present low sirtuin 1 as a candidate marker for bone risk in new diabetes and a thread for follow-up work.
Catalog record
| CREATOR | Yao Xu, Tianxiao Hu, Peiwu Jiang, Xiujing Wang, Jiaqi Yao, Huiling Shen, Zhenying Zhang, Bojing Zheng, Ting Wang, Yanxia Ren, Jing Wang, Qingying Tan |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 24 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |